medigraphic.com
ISSN 2683-1678 (Print)
Órgano Oficial de la Sociedad
Latinoamericana de lnfectología Pediátrica.
Órgano de la Asociación Mexicana de
Infectología Pediátrica, A.C.
Órgano difusor de la Sociedad Española
de lnfectología

2020, Number 3

<< Back Next >>

Rev Latin Infect Pediatr 2020; 33 (3)

SARS-CoV-2; Virus characteristics and transmission

Aguilar GNE, Hernández SAA, Ibanes GC

Language: Spanish
References: 22
Page: 143-148
PDF size: 235.97 Kb.


ABSTRACT

Since the first described cases of SARS-CoV-2 infection (COVID-19) in December 2019 in Wuhan, Hubei Province, China, the pandemic has affected 216 countries in the world and has caused a public health emergency. Understanding the virus and its ability to cause disease has been the main focus of current literature; however, there is much unknown. The knowledge of the potential routes of transmission of SARS-CoV-2 (respiratory/droplets, indirect, fecal-oral, vertical, sexual, and ocular) are important in clinical practice, especially in taking preventative measures to mitigate the spread of SARS-CoV-2. We present a review of the literature on the characteristics of the virus, epidemiology and transmission mechanisms recently described.


REFERENCES

  1. Bennett JE, Dolin R, Blaser MJ, editors. Principles and practice of infectious diseases. 9th ed. Philadelphia: Churchill Livingstone, 2020.

  2. Cui J, Li F, Shi ZL. Origin and evolution of pathogenic coronaviruses. Nat Rev Microbiol. 2019; 17 (3): 181-192.

  3. Coronavirus disease (COVID-19) outbreak situation. (2020). Recovered September 8, 2020, World and Health Organization website: https://www.who.int/emergencies/diseases/novel-coronavirus-2019.

  4. Forster P, Forster L, Renfrew C et al. Phylogenetic network analysis of SARS-CoV-2 genomes. PNAS. 2020; 117 (17): 9241-9243.

  5. Tang X, Wu C, Li X et al. On the origin and continuing evolution of SARS-CoV-2. National Science Review. 2020; 7 (6): 1012-1023.

  6. Liu Y, Eggo RM, Kucharski AJ. Secondary attack rate and superspreading events for SARS-CoV-2. Lancet. 2020; 395 (10227): e47.

  7. Kolifarhood G, Aghaali M, Mozafar SH et al. Epidemiological and clinical aspects of COVID-19; a narrative review. Arch Acad Emerg Med. 2020; 8 (1): e41.

  8. Tang B, Wang X, Li Q et al. Estimation of the transmission risk of the 2019-nCoV and its implication for public health interventions. J Clin Med. 2020; 9 (2): 462.

  9. Gralinski LE, Menachery VD. Return of the coronavirus: 2019-nCoV. Viruses. 2020; 12 (2): 135.

  10. Wong G, Liu W, Liu Y et al. MERS, SARS, and Ebola: the role of super-spreaders in infectious disease. Cell Host Microbe. 2015; 18 (4): 398-401.

  11. Liu Y, Eggo RM, Kucharski AJ. Secondary attack rate and superspreading events for SARS-CoV-2. Lancet. 2020; 395 (10227): e47.

  12. Nishiura H, Oshitani H, Kobayashi T et al. Closed environments facilitate secondary transmission of coronavirus disease 2019 (COVID-19). 2020. doi: https://doi.org/10.1101/2020.02.28.20029272.

  13. Patel K, Vunnam S, Patel P et al. Transmission of SARS-CoV-2: an update of current literature. Eur J Clin Microbiol Infect Dis. 2020: 1-7. Available in: https://doi.org/10.1007/s10096-020-03961-1.

  14. Asadi S, Bouvier N, Wexler A et al. The coronavirus pandemic and aerosols: does COVID-19 transmit via expiratory particles? American Association for Aerosol Research. 2020; 635-638.

  15. Van Doremalen N, Bushmaker T, Morris DH et al. Aerosol and surface stability of SARS-CoV-2 as compared with SARS-CoV-1. N Engl J Med. 2020; 382 (16): 1564-1567.

  16. Blocken B, Malizia F, van Druenen T, Marchal T. Towards aerodynamically equivalent COVID-19 1.5 m 180 social distancing for walking and running. Urban physics, wind engineering & sports aerodynamics, 2020.

  17. Van Doremalen N, Bushmaker T, Morris DH et al. Aerosol and surface stability of SARS-CoV-2 as compared with SARS-CoV-1. N Engl J Med. 2020; 382 (16): 1564-1567.

  18. Shereen M, Khan S, Kazmi A et al. COVID-19 infection: origin, transmission, and characteristics of human coronaviruses. Journal of Advanced Research. 2020; 24: 91-98.

  19. Arons MM, Hatfield KM, Reddy SC et al. Presymptomatic SARS-CoV-2 infections and transmission in a skilled nursing facility. N Engl J Med. doi: 10.1056/NEJMoa2008457.

  20. Chen X, Yu H, Mei T. SARS-CoV-2 on the ocular surface: is it a truly novel transmission route? Br J Ophthalmol. 2020; 0: 1-6.

  21. Chang L, Yan Y, Wang L. Coronavirus disease 2019: coronaviruses and blood safety. [published online ahead of print, 2020 Feb 21]. Transfus Med Rev. 2020; doi: 10.1016/j.tmrv.2020.02.003.

  22. Qian G, Yang N, Yan MA et al. COVID-19: transmission within a family cluster by presymptomatic carriers in China. Clin Infect Dis. 2020; 71 (15): 861-862.




2020     |     www.medigraphic.com